PRLog (Press Release) - Jan. 23, 2013 - Research Triangle Park, NC: MethodSense executive, Rita King, was recently interviewed by MEDS Magazine to discuss the rapid evolution of the technology in the life science industry, specifically in medical devices, and what that means for the medical device commercialization process. The interview runs in the January 2013 edition of the magazine and will be available in both print and on the web.
MEDS (Medical Electronic Device Solutions) Magazine, asked King about what the life science submission and compliance landscape looks like in 2013 and beyond. Specifically, they discussed the role MethodSense and their quality and regulatory software product, InfoStrength, play in terms of facilitating a smooth, unencumbered FDA submission for their clients. Readers of the interview will gain insight from a noted regulatory and quality professional, identify industry trends and learn of the challenges facing the medical device market today.
“The regulatory scrutiny products and companies face is greater than ever,” said King. “I am happy to share our experiences with MEDS Magazine’s readers about what these changes mean for organizations as they prepare for medical submissions and regulatory review.”
Rita King has served as a regulator, technologist and professional auditor for more than 23 years, garnering a well-deserved international reputation as a regulatory expert. A founding member of the Underwriters Laboratories team that defined, launched, and managed the operations of the first US program to evaluate safety critical software used in commercial and medical devices and developed the ANSI approved Standard for Safety Critical Software, UL 1998, King now is owner of MethodSense a life science consulting company.
About MEDS Magazine:
MEDS is published by the RTC Group, which has 20 years of history in the embedded industry and many loyal followers. MEDS (Medical Electronic Device Solutions) is a must-read publication for Medical Device Developers. The publication works with the leading developers, researchers, compliance agencies, companies who perform testing and consultants to search for the best design and manufacturing practices.
About MethodSense, Inc:
MethodSense, developer of quality management software InfoStrength Smart Enterprise Suite, is a life science consulting firm, specializing in helping companies bring medical and technological products to market. They guide medical device, biotech and pharmaceutical companies with quality, regulatory and technology solutions, which enable clients to operate more effectively during the commercialization process and beyond. MethodSense is located in the heart of Research Triangle Park, North Carolina – home to one of the world’s largest biotechnology clusters and a hub for technology-based innovation.